F-star Therapeutics Overview

F-star Therapeutics Selling, General & Admin

Selling, General & Admin expenses for FSTX.

Quarterly SG&A Expenses

$5.16M

↓ 1.49% YoY

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$23.28M

↓ 2.49% YoY

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin